KMA Land1d
KMAland Boys Basketball (2/6): Sholes posts triple-double for Essex, Johnson-Brock on to Pioneer 'ship
Isaiah Sholes had another triple-double for Essex in a defeat, Lo-Ma edged Ar-We-Va, IKM-Manning got 31 from Ben Ramsey, ...
Business Weekly3d
Solid gold future as Astex pursues further growth in wake of silver jubilee
Cambridge biotech company Astex belatedly celebrated its 25th anniversary in style with UK Science Minister and new trade ...
Pharmabiz3d
EMA committee recommends extension of marketing authorisation for Janssen-Cilag’s subcutaneous Rybrevant to treat advanced EGFR-mutated NSCLC
EMA committee recommends extension of marketing authorisation for Janssen-Cilag’s subcutaneous Rybrevant to treat advanced EGFR-mutated NSCLC: Beerse, Belgium Tuesday, February ...
Halozyme Says CHMP Recommends Approval Of Subcutaneous Rybrevant Developed With ENHANZE In NSCLC
Janssen-Cilag International NV, a Johnson & Johnson company, received European Medicines Agency's Committee for Medicinal Products ...
Halozyme announces positive opinion in EU for rybrevant with Enhanze technology
Halozyme (HALO) announced that Janssen-Cilag International, a Johnson & Johnson (JNJ) company, received a positive opinion from the ...
manilatimes4d
CHMP recommends subcutaneous RYBREVANT® (amivantamab) for the treatment of patients with advanced EGFR-mutated non-small cell lung cancer
As monotherapy for treatment of adult patients with advanced NSCLC with activating EGFR exon 20 insertion mutations, after failure of platinum-based therapy.